CureVac N.V.

NASDAQ: CVAC · Real-Time Price · USD
5.50
-0.01 (-0.18%)
At close: Aug 15, 2025, 2:32 PM

CureVac Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
535.18M 53.76M 67.42M 102.99M
Cost of Revenue
105.83M 124.37M 183.99M 238.19M
Gross Profit
429.35M -70.61M -116.57M -135.21M
Operating Income
177.68M -274.21M -249.46M -412.26M
Interest Income
12.36M 16.73M 4.01M 10.1M
Pretax Income
190.88M -259.97M -249.16M -412.5M
Net Income
162.19M -260.17M -249.03M -411.72M
Selling & General & Admin
74.33M 76.43M 89.41M 88.94M
Research & Development
153.03M 115.72M 62.55M 815.91M
Other Expenses
37.81M 11.44M -17.68M -627.79M
Operating Expenses
251.67M 203.6M 134.28M 277.06M
Interest Expense
n/a 2.49M 3.71M 10.34M
Selling & Marketing Expenses
4.45M 424K 417K 1.74M
Cost & Expenses
357.5M 327.96M 318.27M 515.25M
Income Tax Expense
28.7M 198K -126K -782K
Shares Outstanding (Basic)
224.38M 220.48M 189.07M 186.01M
Shares Outstanding (Diluted)
225.27M 220.83M 189.07M 186.01M
EPS (Basic)
0.72 -1.18 -1.32 -2.21
EPS (Diluted)
0.72 -1.18 -1.32 -2.21
EBITDA
209.69M -234.09M -209.39M -386.49M
EBIT
190.88M -257.48M -245.45M -402.16M
Depreciation & Amortization
18.81M 23.39M 26.16M 35.88M